Reply: Correspondence to Efficacy of a Tumor necrosis Factor Inhibitor in Chronic Low-Back Pain with Modic type 1 Changes: A Randomized Controlled Trial.

IF 10.9 1区医学 Q1 RHEUMATOLOGY

Arthritis & Rheumatology Pub Date : 2025-07-07 DOI:10.1002/art.43309

Elisabeth Gjefsen,Lars C Bråten,Ansgar Espeland,Guro L Goll,Kjersti Storheim,John A Zwart

引用次数: 0

查看原文本刊更多论文

回复：肿瘤坏死因子抑制剂对慢性腰痛伴1型改变疗效的对应关系：一项随机对照试验。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Arthritis & Rheumatology RHEUMATOLOGY-

CiteScore

20.90

自引率

3.00%

发文量

371

期刊介绍： Arthritis & Rheumatology is the official journal of the American College of Rheumatology and focuses on the natural history, pathophysiology, treatment, and outcome of rheumatic diseases. It is a peer-reviewed publication that aims to provide the highest quality basic and clinical research in this field. The journal covers a wide range of investigative areas and also includes review articles, editorials, and educational material for researchers and clinicians. Being recognized as a leading research journal in rheumatology, Arthritis & Rheumatology serves the global community of rheumatology investigators and clinicians.